Your browser doesn't support javascript.
loading
Personalized Treatment Strategies Effective in Hypertrophic Cardiomyopathy Do Not Rely on Genomics in 2022: A Different Tale of Precision Medicine.
Maron, Barry J; Maron, Martin S; Sherrid, Mark V; Ommen, Steve R; Rowin, Ethan J.
Affiliation
  • Maron BJ; HCM Center, Lahey Hospital and Medical Center, Burlington, Massachusetts.
  • Maron MS; HCM Center, Lahey Hospital and Medical Center, Burlington, Massachusetts.
  • Sherrid MV; Hypertrophic Cardiomyopathy Program, Division of Cardiology. New York University Langone Health, New York, New York.
  • Ommen SR; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
  • Rowin EJ; HCM Center, Lahey Hospital and Medical Center, Burlington, Massachusetts. Electronic address: ethan.rowin@lahey.org.
Am J Cardiol ; 183: 150-152, 2022 11 15.
Article in En | MEDLINE | ID: mdl-36114018
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Hypertrophic / Precision Medicine Limits: Humans Language: En Journal: Am J Cardiol Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Hypertrophic / Precision Medicine Limits: Humans Language: En Journal: Am J Cardiol Year: 2022 Document type: Article Country of publication: United States